HiFiBiO grabs $75m Series D

HiFiBiO Therapeutics, a multinational biotechnology company, has secured $75 million in Series D financing.

HiFiBiO Therapeutics, a multinational biotechnology company, has secured $75 million in Series D financing. Mirae Asset Financial Group led the round.

Source: Press Release